Triple BRAFinh/MEKinh /antiPD1 Combined Therapy in Patients With BRAF Mutated Melanoma With Central Nervous System Metastasis
Clinical trial NCT05510466 · UNKNOWN
Trial details
- NCT number
- NCT05510466
- Sponsor
- University Hospital, Montpellier
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-01
- Primary completion
- 2023-02-20
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.